Today’s AI Top Pick: PSIX
8/3/2026 · Highly Shorted Oversold screen · a free sample of K3vl4r’s AI-curated picks.
AI-ranked from a screened shortlist, with entry strategy, targets, and risks.
View the live PSIX price forecast →
PSIX (Power Solutions International) is the standout pick because it uniquely combines a top-tier fundamental_score of 7.5 with the most explosive multi-timeframe forecast pattern in the pool. The valuation is genuinely cheap for a growth name: trailing PE 6.23, fwdPe 7.2, PEG 1.21, ROE 75.67%, operMargin 13.48%, profitMargin 14.28%, and salesYoY +38.63% — this is not a broken business, it's a profitable industrial growing at a strong clip that has been marked down 51.68% YTD and 70.55% over the past year, leaving a 64.74% drawdown from its weekly high and a 46.88% drop over the last 21 weekly bars. Analyst recom is 1.67 with targetUpsidePct of 154.9%. The tape confirms with rare force. Every intraday and daily forecast is triple-digit or near it: 1h fc_short/mid/long = 138.31 / 140.18 / 146.06; 4h = 113.22 / 113.32 / 109.20; 1d = 123.99 / 148.42 / 133.46. Bullish_prob is 1.0 and near_term_bullish is 1.0. Positioning is at the bottom of the range (pos_in_21bar_range_pct = 0 on 1h/4h, 23.4 on 1d) with drawdowns of -20.7% / -27.8% / -23.5% — this is a deep oversold coil, not a chase. Adding fuel: the July 27 announcement of Richard Hu as CEO effective August 17 is a clean, imminent catalyst. The honest caveat is the 1wk forecast row (-13.4 / -25.6 / -24.5), which reflects the higher-timeframe damage of the -46.88% weekly move. I treat this as swing-trade friction, not a disqualifier, because the daily/4h/1h all point sharply higher off deeply washed-out lows and the fundamentals do NOT support that weekly bear extrapolation. TOYO has a slightly higher fundamental_score (8) but its weekly forecast is negative and near_term_bullish is only 0.4; BIRK's fundamentals are excellent but forecast magnitudes are muted (1d fc_long only 8.64%, weekly negative); WING has good mid/long forecasts but weaker 1h/4h and a stretched fwdPe of 24.1. PSIX is the only name where fundamentals, forecast magnitude, deep oversold structure, AND a scheduled positive catalyst all line up. Today is the entry, not next week, because PSIX is sitting at a 21-bar low on both the 1h and 4h with all near-term forecasts pointing 100%+ higher and the CEO transition lands in ~2 weeks. Waiting for a bounce sacrifices most of the asymmetric setup.
- Weekly forecast is negative (-13.4% / -25.6% / -24.5%) — if the higher-timeframe downtrend reasserts, near-term bounces can fail quickly
- Perf Year -70.55% and 21wk drawdown -64.74% mean this is a knife-catch by definition; volatility can easily produce 15–20% adverse moves
- ShortFloat 20.62% cuts both ways — a squeeze fuels upside, but concentrated shorts often reflect a bear thesis (customer concentration, related-party history) that could resurface
- CEO transition on Aug 17 is a catalyst but also an execution risk — any early strategic 'reset' commentary could disappoint
- Small cap ($636M) with debtEq 0.90 — thin liquidity magnifies both directions
| # | Symbol | Verdict | Score | Read |
|---|---|---|---|---|
| 1 | PSIX | BUY NOW | 8.7 | Cheap profitable growth with triple-digit near-term forecasts, at 21-bar lows, plus an imminent CEO catalyst on Aug 17. |
| 2 | WING | BUY NOW | 8.0 | Elite franchise economics with 1d/1wk forecasts of +79%/+72% after a -65% yearly drawdown; slightly rich fwdPe is the only knock. |
| 3 | ADTN | BUY NOW | 7.6 | PEG 0.17 with 1h fc_long +88% and 4h +40%, cheap forward multiple, price-target cuts already digested. |
| 4 | BIRK | BUY PULLBACK | 7.3 | Best fundamentals in pool (16% profit margin, PEG 0.88) but forecast magnitudes are modest and 1wk is slightly negative. |
| 5 | PHAT | BUY NOW | 7.1 | Clean multi-timeframe agreement (1h/4h/1d all +18–47%) with recom 1.30 and 150% analyst upside; specialty pharma with growing revenue (+110% YoY). |
| 6 | MNRO | BUY NOW | 6.7 | Every timeframe bullish (1d fc_long +49.7%, 1wk +71.4%), at range bottom, recom 2.2, but low ROE (1.36%) and negative Q2 headline flow. |
| 7 | ARRY | BUY NOW | 6.5 | Atlas platform launch as catalyst, 1d/1wk forecasts +48%/+88%, position_in_range 0 on 1h/4h; -43% YTD makes reward/risk favorable. |
| 8 | DFH | BUY PULLBACK | 6.3 | PE 9, ROE 9.58% with 1d fc_long +71.9%, but Q2 EPS miss ($0.27 vs $0.29) and recom of 3.0 are drags. |
| 9 | CRML | BUY PULLBACK | 6.0 | Massive 1h/4h forecasts (+114% / +90%) and 241% analyst upside, but no revenue yet and negative asset-review headlines cap conviction. |
| 10 | SERV | BUY PULLBACK | 5.9 | 1d fc_short/mid/long all +105–120% with 282% analyst upside, but operMargin -2843% and profitMargin -2640% make this pure narrative. |
| 11 | LAC | BUY PULLBACK | 5.7 | 1h/4h forecasts +62–74% with 92% analyst upside and lithium cycle, but pre-revenue and only 0.6 near-term bullish. |
| 12 | ABAT | BUY PULLBACK | 5.5 | DOE $57M grant reinstated is a real catalyst and 1h/4h forecasts +74–90%, but operMargin -390% and 1wk forecast negative. |
| 13 | CDZI | BUY PULLBACK | 5.2 | Real project momentum (Mojave pipeline agreements) with 267.9% analyst upside, but debtEq 7.53 and profitMargin -255% require patience. |
| 14 | LUNR | BUY PULLBACK | 5.1 | 1h fc +166–180% and 4h +38–105% but 1wk forecast row deeply negative (-24 to -36%) and fwdPe of 897 is stretched. |
| 15 | RUN | WAIT | 5.0 | 1wk fc_long +98% is enticing but epsNextY -61.62% and debtEq 4.45 with pending earnings introduce binary risk. |
| 16 | ACI | BUY PULLBACK | 4.9 | Insider buying and 1d/1wk forecasts +48%/+71% but PE 154.8, debtEq 9.74, and profitMargin 0.08% cap upside. |
| 17 | VERA | WAIT | 4.6 | FDA approval for TRUTAKNA is bullish but 1h/1wk forecasts are negative and multi-timeframe not aligned. |
| 18 | PZZA | WAIT | 4.5 | All timeframes moderately bullish but only 24% analyst upside, PT cut by Mizuho to $32, weak grossMargin 15.94%. |
| 19 | FLO | AVOID | 4.3 | First dividend cut in 24 years just landed; even if forecasts show +100%+ on weekly, thesis is fundamentally impaired. |
| 20 | LFMD | BUY PULLBACK | 4.3 | All timeframes bullish and recom 1.0 but ROE -249% and PEG 6.34 make this speculative. |
| 21 | WU | AVOID | 4.2 | Just cut 2026 guidance (7/31), recom 3.86, and only 14% analyst upside — cheap for a reason. |
| 22 | NTLA | WAIT | 4.0 | Wolfe downgrade to Underperform with $9 PT and skeptical SeekingAlpha coverage; forecasts moderate at best. |
| 23 | TOYO | WAIT | 3.9 | Fundamentals look great on paper (PEG 0.03, ROE 46.5%) but 1d/1wk forecasts negative, near_term_bullish only 0.4, ADR verification risk. |
| 24 | AMR | AVOID | 3.7 | Just cut FY26 met coal sales guidance from 14.54–15.4M to 13.2–14.0M tons; forecasts positive but fundamentals deteriorating. |
| 25 | METC | AVOID | 3.4 | fwdPe 179.42, Goldman cut PT to $13, negative Q2 expected — screen match without a thesis. |
| 26 | EVMN | AVOID | 3.3 | OperMargin -900%, profitMargin -760%, no clear catalyst path despite insider buying. |
| 27 | CAR | AVOID | 3.0 | Verra Mobility deal reset on less favorable terms is a negative catalyst; targetUpsidePct -6% is a red flag. |
| 28 | TDOC | AVOID | 2.8 | Stock plummeted on Q2 miss on 7/30; 1h/1d/1wk forecasts negative to flat, recom 2.64. |
| 29 | FLGT | AVOID | 2.7 | Q2 miss and guidance cut on 7/30, -37% YTD, targetUpsidePct -9.4%, recom 3.0. |
| 30 | QCLS | AVOID | 1.5 | bullish_prob 0 and 1wk forecasts all -100%; microcap ($20M) with catastrophic multi-timeframe warning. |
Get AI top picks & forecasts on any stock
K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord